Literature DB >> 26393032

Completeness and accuracy of electronic recording of paediatric drug-resistant tuberculosis in Cape Town, South Africa.

P C Rose1, H S Schaaf2, K du Preez1, J A Seddon3, A J Garcia-Prats1, K Zimri1, R Dunbar1, A C Hesseling1.   

Abstract

SETTING: Cape Town, South Africa.
OBJECTIVE: To assess the completeness and accuracy of electronic recording of drug-resistant tuberculosis (DR-TB) in children.
DESIGN: Retrospective cohort study. All children aged <15 years treated for DR-TB during 2012 were included, with clinical data collected from routine health services. Matching was performed between clinical data and an extracted data set from an electronic register for DR-TB (EDR.web), and data sources were compared.
RESULTS: Seventy-seven children were identified clinically, of whom only 49 (64%) were found in EDR.web. Most data in EDR.web were complete and accurate, but there were some internal inconsistencies for confirmed TB. Only 4.4% of all EDR.web entries were children.
CONCLUSION: Only two thirds of children clinically treated for DR-TB were recorded in the electronic reporting system, suggesting under-reporting. We also found a lower than expected prevalence of childhood DR-TB, probably suggesting both under-diagnosis and under-recording of DR-TB in children. Clinicians at facility level should be able to access the electronic reporting system, and data transfer between clinical paper-based and electronic sources should be simplified. Cross-linking between electronic registers for drug-susceptible and DR-TB or consolidation of registers could improve the accuracy of recording. Improved recording and reporting of DR-TB in children is needed.

Entities:  

Keywords:  TB; children; drug resistance; registration; surveillance

Year:  2013        PMID: 26393032      PMCID: PMC4463121          DOI: 10.5588/pha.13.0041

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  7 in total

Review 1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Prev Med       Date:  2007-09-04       Impact factor: 4.018

2.  Electronic tuberculosis surveillance systems: a tool for managing today's TB programs.

Authors:  P Nadol; K W Stinson; W Coggin; M Naicker; C D Wells; B Miller; L J Nelson
Journal:  Int J Tuberc Lung Dis       Date:  2008-03       Impact factor: 2.373

3.  Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome.

Authors:  James A Seddon; Anneke C Hesseling; Marianne Willemse; Peter R Donald; H Simon Schaaf
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

4.  Incomplete registration and reporting of culture-confirmed childhood tuberculosis diagnosed in hospital.

Authors:  K du Preez; H S Schaaf; R Dunbar; A Swartz; K Bissell; D A Enarson; A C Hesseling
Journal:  Public Health Action       Date:  2011-09-21

Review 5.  The burden of childhood tuberculosis: a public health perspective.

Authors:  B J Marais; C C Obihara; R M Warren; H S Schaaf; R P Gie; P R Donald
Journal:  Int J Tuberc Lung Dis       Date:  2005-12       Impact factor: 2.373

6.  Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number.

Authors:  Nora Méray; Johannes B Reitsma; Anita C J Ravelli; Gouke J Bonsel
Journal:  J Clin Epidemiol       Date:  2007-05-17       Impact factor: 6.437

7.  The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

Authors:  J A Seddon; A C Hesseling; B J Marais; A Jordaan; T Victor; H S Schaaf
Journal:  Int J Tuberc Lung Dis       Date:  2012-05-08       Impact factor: 2.373

  7 in total
  9 in total

1.  Childhood tuberculosis: no longer an orphan disease?

Authors:  Nulda Beyers; Robert Gie
Journal:  Public Health Action       Date:  2013-09-21

2.  Assessing the feasibility of introducing an electronic health information system into Tuberculosis clinics and laboratories in Myanmar.

Authors:  Kazuki Miyazaki; Ikuma Nozaki; Bumpei Tojo; Kazuhiko Moji
Journal:  Glob Health Med       Date:  2020-08-31

3.  Data quality assessment of a South African electronic registry for drug-resistant TB, 2015-2016.

Authors:  R Manesen; K A Mekler; T R Molobi; A A Tyiki; M J Madlavu; K Velen; S Charalambous; Y F van der Heijden
Journal:  Public Health Action       Date:  2021-03-21

Review 4.  Tuberculosis in children.

Authors:  Ben J Marais; H Simon Schaaf
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

Review 5.  Availability and quality of routine morbidity data: review of studies in South Africa.

Authors:  Rifqah A Roomaney; Victoria Pillay-van Wyk; Oluwatoyin F Awotiwon; Edward Nicol; Jané D Joubert; Debbie Bradshaw; Lyn A Hanmer
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

6.  Is the routine health information system ready to support the planned national health insurance scheme in South Africa?

Authors:  Edward Nicol; Lyn A Hanmer; Ferdinand C Mukumbang; Wisdom Basera; Andiswa Zitho; Debbie Bradshaw
Journal:  Health Policy Plan       Date:  2021-06-01       Impact factor: 3.344

7.  Evaluating the electronic tuberculosis register surveillance system in Eden District, Western Cape, South Africa, 2015.

Authors:  Mandla Mlotshwa; Sandra Smit; Seymour Williams; Carl Reddy; Andrew Medina-Marino
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

8.  Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa.

Authors:  Lise Jamieson; Denise Evans; Rebecca Berhanu; Nazir Ismail; Samantha Aucock; Kristina Wallengren; Lawrence Long
Journal:  BMC Public Health       Date:  2019-12-05       Impact factor: 3.295

9.  Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008-2010.

Authors:  Brittany K Moore; Linda Erasmus; Julia Ershova; Sarah E Smith; Norbert Ndjeka; Laura J Podewils
Journal:  PLoS One       Date:  2020-04-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.